Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2021-07-20 00:00:00 ET · period of report 2021-07-16 · accession 0000899243-21-029107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-20 | 2021-07-16 | CLOV | Reynoso Jamie L. | COO | A - Grant | $0.00 | +220.8K | 220.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-16 | A | A | 220,820 | $0.00 | 220,820 | D | — | — | (F1) Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in equal annual installments over four years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person on each vesting date. |